Finance

Lists
688513:SHA
Chengdu Easton Biopharmaceuticals Co Ltd
45,39 CNY
-1,33%
(-0,61) 1D
16 ოქტ, 15:00:00 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688513...
Open
46,49 CNY
High
48,45 CNY
Low
45,18 CNY
Mkt. cap
8,12 მლრდ.
Avg. vol.
1,91 მლნ.
Volume
2,01 მლნ.
Dividend
1,08%
Quarterly dividend
0,12 CNY
Ex-dividend date
2 ივნ. 2026
P/E ratio
28,35
52-wk high
80,48 CNY
52-wk low
40,25 CNY
EPS
1,60 CNY
No. of employees
1 ათ.
Open
46,49 CNY
High
48,45 CNY
Low
45,18 CNY
Mkt. cap
8,12 მლრდ.
Avg. vol.
1,91 მლნ.
Volume
2,01 მლნ.
Dividend
1,08%
Quarterly dividend
0,12 CNY
Ex-dividend date
2 ივნ. 2026
P/E ratio
28,35
52-wk high
80,48 CNY
52-wk low
40,25 CNY
EPS
1,60 CNY
No. of employees
1 ათ.
News stories
From web sources and news partners
About Chengdu Easton Biopharmaceuticals Co Ltd
CEO-
Employees1,42 ათ.
Founded1 ივნ. 2009
Headquarters-
SectorPharmaceutical industry
Websiteeastonpharma.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
364,69 მლნ.
312,26 მლნ.
326,26 მლნ.
332,64 მლნ.
Cost of goods sold
87,18 მლნ.
88,47 მლნ.
73,62 მლნ.
82,94 მლნ.
Cost of revenue
87,18 მლნ.
88,47 მლნ.
73,62 მლნ.
82,94 მლნ.
Research and development expenses
54,95 მლნ.
79,44 მლნ.
72,66 მლნ.
77,99 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
136,71 მლნ.
128,80 მლნ.
143,86 მლნ.
107,14 მლნ.
Operating expense
197,59 მლნ.
214,09 მლნ.
212,02 მლნ.
195,99 მლნ.
Total operating expenses
284,77 მლნ.
302,56 მლნ.
285,64 მლნ.
278,93 მლნ.
Operating income
79,91 მლნ.
9,70 მლნ.
40,62 მლნ.
53,71 მლნ.
Other non operating income
-228,90 ათ.
230,85 ათ.
-519,09 ათ.
493,27 ათ.
EBT including unusual items
92,35 მლნ.
57,56 მლნ.
47,40 მლნ.
86,84 მლნ.
EBT excluding unusual items
79,77 მლნ.
51,53 მლნ.
41,48 მლნ.
54,72 მლნ.
Income tax expense
8,76 მლნ.
4,15 მლნ.
4,12 მლნ.
18,02 მლნ.
Effective tax rate
9,49%
7,21%
8,69%
20,75%
Other operating expenses
4,49 მლნ.
8,00 მლნ.
-4,46 მლნ.
11,52 მლნ.
Net income
83,59 მლნ.
63,90 მლნ.
50,83 მლნ.
78,92 მლნ.
Net profit margin
22,92%
20,46%
15,58%
23,73%
Earnings per share
-
-
-
-
Interest and investment income
733,65 ათ.
42,65 მლნ.
1,95 მლნ.
2,46 მლნ.
Interest expense
-615,69 ათ.
-622,07 ათ.
-575,93 ათ.
-792,69 ათ.
Net interest expenses
117,96 ათ.
42,02 მლნ.
1,38 მლნ.
1,67 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
100,25 მლნ.
32,44 მლნ.
63,37 მლნ.
81,43 მლნ.
Gain or loss from assets sale
-
-29,35 ათ.
-
-18,53 ათ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები